90 related articles for article (PubMed ID: 20586100)
1. Surrogate end-points for treatment trials of hepatitis B virus.
Griffiths PD
Rev Med Virol; 2010 Jul; 20(4):199-201. PubMed ID: 20586100
[No Abstract] [Full Text] [Related]
2. Navigating the maze of hepatitis B treatments.
Lok AS
Gastroenterology; 2007 Apr; 132(4):1586-94. PubMed ID: 17408643
[No Abstract] [Full Text] [Related]
3. Treatment of chronic hepatitis B with a combination of acyclovir and alpha-lymphoblastoid interferon.
Schalm SW
J Chemother; 1989 Jul; 1(4 Suppl):1112-4. PubMed ID: 16312795
[No Abstract] [Full Text] [Related]
4. [Tenofovir, An antiviral agent with activity against HIV infections and hepatitis B].
Taéron C
Rev Infirm; 2009 Sep; (153):49-51. PubMed ID: 19771814
[No Abstract] [Full Text] [Related]
5. Introduction to 'Hepatitis B virus heterogeneity--a means to personalized care'.
Bonino F;
Antivir Ther; 2010; 15 Suppl 3():1-2. PubMed ID: 21041898
[No Abstract] [Full Text] [Related]
6. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G
Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847
[TBL] [Abstract][Full Text] [Related]
7. Delivery of hepatitis B virus therapeutic agents using asialoglycoprotein receptor-based liver-specific targeting.
Konishi M; Wu CH; Wu GY
Methods Mol Med; 2004; 96():163-73. PubMed ID: 14762268
[No Abstract] [Full Text] [Related]
8. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation.
Ben-Ari Z; Zemel R; Kazetsker A; Fraser G; Tur-Kaspa R
Am J Gastroenterol; 1999 Mar; 94(3):663-7. PubMed ID: 10086648
[TBL] [Abstract][Full Text] [Related]
10. Residual hepatitis B virus particles in liver transplant recipients receiving lamivudine: PCR quantitation of HBV DNA and ELISA of preS1 antigen.
Petit MA; Buffello-Le Guillou D; Roche B; Dussaix E; Duclos-Vallée JC; Féray C; Samuel D
J Med Virol; 2001 Nov; 65(3):493-504. PubMed ID: 11596084
[TBL] [Abstract][Full Text] [Related]
11. [Lamivudine treatment consensus from relative experts].
Lamivudine Clinical Practice Group
Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):157-8. PubMed ID: 12108391
[No Abstract] [Full Text] [Related]
12. A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection.
Mazur W; Król F; Cianciara J; Nazzal K; Gładysz A; Juszczyk J; Bolewska B; Adamek J; Czajka B; Swietek K; Kryczka W; Gonciarz Z
Med Sci Monit; 2002 Apr; 8(4):CR257-62. PubMed ID: 11951067
[TBL] [Abstract][Full Text] [Related]
13. In vitro models for studying hepatitis B virus drug resistance.
Zoulim F
Semin Liver Dis; 2006 May; 26(2):171-80. PubMed ID: 16673295
[TBL] [Abstract][Full Text] [Related]
14. [Hepatological update (7). 2 different phases of chronic hepatitis B--2 different methods of treatment?].
Juszczyk J
Pol Tyg Lek; 1987 Oct; 42(43):1365-8. PubMed ID: 3328179
[No Abstract] [Full Text] [Related]
15. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
[TBL] [Abstract][Full Text] [Related]
16. Antiviral efficacy against hepatitis B virus replication of oleuropein isolated from Jasminum officinale L. var. grandiflorum.
Zhao G; Yin Z; Dong J
J Ethnopharmacol; 2009 Sep; 125(2):265-8. PubMed ID: 19580857
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B escape mutant reactivation in a renal transplant patient.
Le Pendeven C; Cuzon G; Fontaine H; Zatla F; Schneider V; Amiel C; Khayat R; Nicolas JC; Soussan P
J Clin Virol; 2007 Sep; 40(1):74-6. PubMed ID: 17652016
[No Abstract] [Full Text] [Related]
18. Hepatitis B virus-related membranous nephropathy treated with entecavir.
Ikee R; Ishioka K; Oka M; Maesato K; Moriya H; Hidaka S; Ohtake T; Kobayashi S
Nephrology (Carlton); 2010 Mar; 15(2):266. PubMed ID: 20470290
[No Abstract] [Full Text] [Related]
19. Natural history of hepatitis B in perinatally infected carriers.
Boxall EH; Sira J; Standish RA; Davies P; Sleight E; Dhillon AP; Scheuer PJ; Kelly DA
Arch Dis Child Fetal Neonatal Ed; 2004 Sep; 89(5):F456-60. PubMed ID: 15321970
[TBL] [Abstract][Full Text] [Related]
20. Evolution of multi-drug resistant hepatitis B virus during sequential therapy.
Yim HJ; Hussain M; Liu Y; Wong SN; Fung SK; Lok AS
Hepatology; 2006 Sep; 44(3):703-12. PubMed ID: 16941700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
